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Background: Although both vasodilators Dipyridamole (DIP) and Adenosine (AD) are 
used in myocardial perfusion imaging (MPI), diagnostic superiority of either has not been 
demonstrated. We compared diagnostic accuracy in a randomized population for detect- 
ing coronary artery disease (CAD). 
Methods: A total of 1139 consecutive patients referred for vasodilator stress MPI were 
randomized to receive either AD (47.8%) or DIP (52.2%), followed by Tc-99m Sestamibi 
SPECT imaging. Of these, 129 patient (11.3%) underwent coronary angiography within 6 
months of stress MPI. Patients with prior bypass surgery were excluded. SPECT images 
were read blindly by a consensus of 3 nuclear cardiologists, and were classified as 
abnormal if fixed or reversible defects were present. Coronary angiograms were classi- 
fied as positive for obstructive CAD if a >=70% stenosis was present in a major coronary 
vessel. Severity of CAD was quantified using the Califf model. Califf scores of 23-37 
were classified as mild to moderate CAD, while scores of 42-100 as moderate to severe 
CAD. 
Introduction: Surwors of sudden cardiac death (SCD) due to ventricular tachycardia 
(VT)/ ventricular fibrillation (VF) are at risk for recurrences. The impact of revasculariza- 
tion in survivors of SCD with coronary artery disease (CAD) is of interest as ischemia 
may serve as a trigger for VTNF. 
Methods: Survivors of SCD with CAD were evaluated according to a standardized proto- 
col in which detection of ischemia plays a key role. All pts underwent 2D echocardio- 
graphy. myocardial perfusion scintigraphy and coronary angiography. Subsequently, 
revascularization of ischemic mvocardial reaions was oerlormed in all ots with scinti- 
graphically-documented ischemia. The second step in the protocol is electrophysiological 
(EPI testino in all ots. Pts with ischemia underwent EP tests after revascularization. Non- 
Results: For all CAD patients, the sensitivity of AD and DIP was 88% and 75% (p=O.O7), 
with specificity of 63% and 61%, respectnely. While the sensitivity for moderate to 
severe CAD was similar, the sensitivity for mild to moderate CAD was significantly 
greater with AD than with DIP (Table). 
CAD Severity Adenosine Dipyridamole p Value 
Mild to Moderate CAD 90% (1 E/20) 62% (1 E/29) 0.035 
Moderate to Severe CAD 87% (20123) 91% (21/23) 0.48 
Conclusion: Adenosine is significantly superior to Dipyridamole as a pharmacologic 
stressor in detecting mild to moderate CAD with nuclear myocardial perfusion imaging. 
inducible and revascularized pts were discharged without ICD, whereas inducible revas- 
cularized and nonrevascularized pts were discharged after ICD implantation, VT ablation 
or with antiarrhythmic drugs (AAD). Furthermore, noninducible nonrevascularized pts 
underwent ICD implantation. 
Results: Of the 142 pts, 44 (31%) pts had myocardial ischemia and were completely 
revascularized. Four-year survival rates were 100% for revascularized non-inducible 
patients, 84% for revascularized inducible patients, 91% for non-revascularized non- 
inducible patients and 72% for non-revascularized inducible patients. Only 1 patient 
(~1% of study population) died suddenly. Recurrences were much more frequent in 
patients without revascularization (38% versus 7%. PcO.001) and the recurrence rate 
was 0% in the revascularized non-inducible patients. 
Conclusion: As a results of sequential evaluation aimed at detection of ischemia and sub- 
sequent revascularization outcome in survivors of SCD is excellent. Revascularized and 
non-inducible pts had a 4.year survival of 100% with a 0% recurrence rate. Only 71% of 
the pts received an ICD. Nuclear perfusion scintigraphy serves as a gatekeeper for ICD 
implantation. 
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CVT-3146 (CVT) is a novel selective A2a adenosine (ADO) agonist, with coronary 
vasodilator effects comparable to ADO, and less effects on peripheral and renal vascula- 
ture, which may result in a more favorable biodistribution and kinetics for stress periusion 
imaging. Accordingly, we evaluated biodistribution, and clearance of Thallium-POl(TL) 
and Tc99m-sestamibi (MIBI) with CVT and ADO in a chronic canine model. Methods: 
Anesthetized close chest dogs (n=6) were instrumented for hemodynamic monitoring 
and blood sampling. Each dog received CVT (2.5 mcglkg) over 30 sec. 10 set later TL 
(1.5 mCi) was injected, and dynamic planar imaging performed over 10 min. Serial blood 
samples were obtained for gamma well counting to determine clearance halftimes. Proto- 
col was repeated on same day with injection of MIBI (25mCi). 1 ‘week later, same proto- 
col was repeated using ADO (280 mcg/kgimin, for 4.5 min). Regions of interest were 
drawn on heart (H) and liver(L) and H/L ratios calculated. Heart uptake (% injected dose) 
was determined using an external reference. Results: CVT and ADO produced compa- 
rable hemodynamic effects, heart uptakes and H/L ratios. Blood clearance of TL and 
MIBI was mono-exoonentlal for both stressors. althouah MIEI clearance was sianificantlv 
Introduction: There IS limited information about contemporary performance of SPECT 
myocardial perfusion imaging in women, especially in regard to certainty of interpreta- 
tions and the contribution of ECG-gating. 
Methods: Randomly presented gated and non-gated SPECT scans (total 636) of 318 
women (209 with cath < 60 days 43 OVD, 58 lVD, 60 2VD, 48 3VD; 109 ~5% CAD like- 
lihood) acquired at 3’different centers were read blindedly by consensus of 3 experi- 
enced readers. The studies (159 TI-201, 159 MIBI) were assessed for quality (good, 
average, poor), diagnosis (definitely normal or abnormal: probably normal or abnormal; 
or equivocal), and interpretation for each coronary territory (normal, reversible or partially 
reversible, fixed perfwon defect). Studies were acquired from 1997 - 2002 using ASNC 
standard procedures. 56% were performed with exercise and 44% with pharmacologic 
stress. Exclusionary criteria were prior CABG or transplant or recent PCI. Results: Mean 
height and weight was 84’ and 170 Ibs. Image quality was graded good in 92%. Diagnos- 
tically certain (DC) interpretations (definitely normal or abnormal) were made for 76% of 
non-gated vs 89% of gated images. Using only DC interpretations for calculations, 
respective sensitivity, specificity and accuracy in the cath population for any CAD was 
91%, 46% and 84% for non-gated, and 86%, 58%, and 82% for gated data. Normalcy 
rates were 71% (nongated) and 91% (gated). Accurate identification of multivessel CAD 
was 78% for non-gated and 81% for gated images. DCA for LAD, RCA, and LCX were 
70%, 69%, and 69% for both non-gated and gated images. Conclusions: This blinded 
interpretation study demonstrates that contemporary SPECT myocardial perfusion imag- 
ing performs extremely well in women, even when diagnostic criteria are predefined for 
only definite interpretations; that diagnostic certainty is very high; and that ECG-gating is 
especially useful in strengthening certainty of interpretation and reducing “false posi- 
tives”. 
- . 
faster than TL, and faster with CVT. Conclusion: CVT stress produced comparable 
imaaes to ADO. Given the observed faster blood clearance of MIBI. a shorter oeriod of 
hyperemia might be sufficient for MIBI perfusion imaging, particularly for CVT stress.> 
* p eO.01 YS TI: t p < 0.05 vs ADO 
Clearance Heart Uptake H/L Ratlo 
Halftime (mm) (% injected dose) 
ADO TL 2.69 * 0.08 4.43 * 1 .Ol 1.41 * 0.21 
ADO MlBl 1.59 * 0.07 * 2.47 * 0.61 0.60 + 0.07 * 
CVTTL 2.51 i 0.17 5.50 * 1.39 1.27kO.14 
CVT MIBI 1.35 * 0.04 ‘t 3.33 * 1.04 0.59 * 0.07 ’ 
